When does exercise hinder rather than halt tumor progression? The decisive role of immunotherapy responsiveness
Proceedings of the National Academy of Sciences · 28.07.2026 · 123 (30)
DOI: 10.1073/pnas.2616250123 ↗Kurz gefasst
Leserbrief in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 17.07.2026. Verfasst von Xin Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Education, Shandong Sport University, Jinan 250102, China. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Graduate School of Education, Shandong Sport University, Jinan 250102, China.
ORCID-Profile: Qinglu Wang
Zitieren
APA
Zhou, X., Liu, J., & Wang, Q. (2026). When does exercise hinder rather than halt tumor progression? The decisive role of immunotherapy responsiveness. Proceedings of the National Academy of Sciences, 123(30). https://doi.org/10.1073/pnas.2616250123
Vancouver
Zhou X, Liu J, Wang Q. When does exercise hinder rather than halt tumor progression? The decisive role of immunotherapy responsiveness. Proceedings of the National Academy of Sciences. 2026;123(30). doi:10.1073/pnas.2616250123
BibTeX
@article{Zhou2026,
author = {Zhou, Xin and Liu, Jingjing and Wang, Qinglu},
title = {When does exercise hinder rather than halt tumor progression? The decisive role of immunotherapy responsiveness},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {30},
doi = {10.1073/pnas.2616250123}
}
EUVIMED